Evaluating the clinical significance of

Acute myeloid leukemia (AML) EFS FLT3-ITD mutation Novel mutation Prognosis

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 20 01 2022
revised: 25 04 2022
accepted: 16 11 2022
entrez: 1 12 2022
pubmed: 2 12 2022
medline: 2 12 2022
Statut: epublish

Résumé

The FMS-like tyrosine kinase-3 internal tandem duplication (

Identifiants

pubmed: 36451749
doi: 10.1016/j.heliyon.2022.e11858
pii: S2405-8440(22)03146-2
pmc: PMC9703599
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e11858

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Leukemia. 2019 Feb;33(2):299-312
pubmed: 30651634
Leuk Lymphoma. 2018 Oct;59(10):2273-2286
pubmed: 29164965
Blood. 2001 Sep 15;98(6):1752-9
pubmed: 11535508
Br J Haematol. 2000 Oct;111(1):190-5
pubmed: 11091200
Gene. 2020 Feb 5;726:144195
pubmed: 31669649
Hematology Am Soc Hematol Educ Program. 2006;:178-84
pubmed: 17124058
Leuk Res. 2018 May;68:51-56
pubmed: 29544132
J Exp Clin Cancer Res. 2007 Sep;26(3):411-5
pubmed: 17987804
J Clin Lab Anal. 2021 Dec;35(12):e24049
pubmed: 34708888
Leuk Res Treatment. 2013;2013:275760
pubmed: 23936658
Cancers (Basel). 2020 Mar 25;12(4):
pubmed: 32218221
Oncoimmunology. 2020 Feb 26;9(1):1731942
pubmed: 32158624
Arch Med Res. 2016 Apr;47(3):172-9
pubmed: 27373815
J Hematol Oncol. 2011 Sep 14;4:36
pubmed: 21917154
J Biomol Struct Dyn. 2021 Sep 6;:1-12
pubmed: 34486940
Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):676-685
pubmed: 34108128
Blood. 2006 May 1;107(9):3724-6
pubmed: 16368883
Oncol Lett. 2019 Dec;18(6):6766-6774
pubmed: 31807186
Front Oncol. 2020 Dec 23;10:612880
pubmed: 33425766
Case Rep Oncol. 2020 Mar 24;13(1):266-270
pubmed: 32308588
Indian J Hematol Blood Transfus. 2018 Jan;34(1):32-42
pubmed: 29398797
Blood Adv. 2019 Jun 11;3(11):1714-1721
pubmed: 31171508
Turk J Haematol. 2017 Dec 1;34(4):300-306
pubmed: 28294102
Blood. 2007 Aug 15;110(4):1262-70
pubmed: 17456725
Leukemia. 2016 May;30(5):1220-1225
pubmed: 26487272
Blood. 2009 Apr 23;113(17):4074-7
pubmed: 18483393
Protein Cell. 2011 Feb;2(2):108-15
pubmed: 21359601
Curr Treat Options Oncol. 2020 Jan 13;21(1):3
pubmed: 31933183
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Blood. 2009 Sep 17;114(12):2386-92
pubmed: 19602710
Genes Chromosomes Cancer. 2012 Oct;51(10):910-24
pubmed: 22674490
Leukemia. 2011 Aug;25(8):1297-304
pubmed: 21537333
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):37-44
pubmed: 29222235
Blood. 2002 Jul 1;100(1):59-66
pubmed: 12070009
Oncol Rev. 2012 Apr 17;6(1):e8
pubmed: 25992210

Auteurs

Yahia Moualla (Y)

Department of Laboratory Diagnosis, Faculty of Pharmacy, Tishreen University, Ministry of Higher Education, Lattakia, Syria.

Faten Moassass (F)

Department of Molecular Biology and Biotechnology, Human Genetics Division, Atomic Energy Commission, Damascus, Syria.

Bassel Al-Halabi (B)

Department of Molecular Biology and Biotechnology, Human Genetics Division, Atomic Energy Commission, Damascus, Syria.

Walid Al-Achkar (W)

Department of Molecular Biology and Biotechnology, Human Genetics Division, Atomic Energy Commission, Damascus, Syria.

Michael Georgeos (M)

Department of Hematology and Oncology, Faculty of Medicine, Tishreen University, Ministry of Higher Education, Lattakia, Syria.

Haissam Yazigi (H)

Department of Laboratory Diagnosis, Faculty of Medicine, Tishreen University, Ministry of Higher Education, Lattakia, Syria.

Atieh Khamis (A)

Department of Laboratory Diagnosis, Faculty of Pharmacy, Tishreen University, Ministry of Higher Education, Lattakia, Syria.

Classifications MeSH